In this issue:
Paediatric psoriasis linked to overweight and obesity
Secukinumab for moderateto- severe plaque psoriasis
The most effective dose of secukinumab
Adherence to medication in psoriasis
Ustekinumab and anti-TNFs in psoriasis + HCV or HBV
Rhinosinusitis without nasal polyps: raised psoriasis risk
Patient-reported reasons for discontinuing systemic therapies
Different analytical methods influence etanercept outcomes
Combinations of classical topical treatments
Determining the optimum acitretin dose
Which LTBI screening strategy during long-term anti-TNFs?
Please login below to download this issue (PDF)